Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration in Patients Aged 90 Years or Older: 2-Year Visual Acuity Outcomes
Eye - United Kingdom
doi 10.1038/s41433-018-0114-3
Full Text
Open PDFAbstract
Available in full text
Date
June 4, 2018
Authors
Publisher
Springer Science and Business Media LLC